E-LIB Suche - Ergebnisse für: Arnason, Jon E.

1

High CD34‐positive cell dose in matched unrelated donor all..:

Avigan, Zachary M. ; Dias, Ajoy L. ; Dodge, Laura E....
Transfusion. 64 (2024) 6 - p. 1068-1075 , 2024

Link: https://doi.org/10.1111/..

2

A phase 2 trial of defibrotide for the prevention of chimer..:

Jacobson, Caron A. ; Rosenthal, Allison C. ; Arnason, Jon E....
Blood Advances. , 2023

Link: https://doi.org/10.1182/..

3

Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimer..:

Kamdar, Manali ; Solomon, Scott R. ; Arnason, Jon E....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S56-S57 , 2022

Link: https://doi.org/10.1016/..

4

Phase II Clinical Trial of Abatacept for Steroid-Refractory..:

Koshy, Anita G. ; Kim, Haesook ; Stroopinsky, Dina...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S29-S30 , 2022

Link: https://doi.org/10.1016/..

5

Improved Quality of Life (QOL) with Lisocabtagene Maraleuce..:

Abramson, Jeremy S. ; Solomon, Scott R. ; Arnason, Jon E....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S188-S189 , 2022

Link: https://doi.org/10.1016/..

6

Two-Year (yr) Follow-up (FU) of Transcend NHL 001, a Multic..:

Abramson, Jeremy S. ; Palomba, M. Lia ; Gordon, Leo I....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S55-S56 , 2022

Link: https://doi.org/10.1016/..

7

Real-World Treatment Patterns After CD19-Directed CAR T Cel..:

Jalbert, Jessica J. ; Wu, Ning ; Chen, Chieh-I...
Advances in Therapy. 39 (2022) 6 - p. 2630-2640 , 2022

Link: https://doi.org/10.1007/..

8

Corticosteroids, Tocilizumab or Filgrastim Do Not Impact th..:

Bindal, Poorva ; Trottier, Caitlin ; Dodge, Laura E....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S196-S197 , 2022

Link: https://doi.org/10.1016/..

9

Development of Novel Second Generation DC/Tumor Fusion Vacc..:

Orr, Shira ; Capelletti, Marzia ; Stroopinsky, Dina...
Biology of Blood and Marrow Transplantation. 26 (2020) 3 - p. S316 , 2020

Link: https://doi.org/10.1016/..

10

Efficacy results of a phase 2 trial of first-line idelalisi..:

Lampson, Benjamin L. ; Kim, Haesook T. ; Davids, Matthew S....
Blood Advances. 3 (2019) 7 - p. 1167-1174 , 2019

Link: https://doi.org/10.1182/..

11

High Durable CR Rates and Preliminary Safety Profile for JC..:

Abramson, Jeremy S. ; Siddiqi, Tanya ; Palomba, M. Lia...
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S25 , 2018

Link: https://doi.org/10.1016/..

12

Phase I Clinical Trial Evaluating Abatacept in Patients wit..:

Nahas, Myrna R. ; Soiffer, Robert J. ; Alyea, Edwin P....
Biology of Blood and Marrow Transplantation. 23 (2017) 3 - p. S376 , 2017

Link: https://doi.org/10.1016/..

13

Targeting B Cell Signaling in Chronic Lymphocytic Leukemia:

Arnason, Jon E. ; Brown, Jennifer R.
Current Oncology Reports. 19 (2017) 9 - p. , 2017

Link: https://doi.org/10.1007/..

14

Targeted Therapy for Chronic Lymphocytic Leukemia: Current ..:

Arnason, Jon E. ; Brown, Jennifer R.
Drugs. 75 (2015) 2 - p. 143-155 , 2015

Link: https://doi.org/10.1007/..

15

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in..:

Rosenblatt, Jacalyn ; Stone, Richard M. ; Uhl, Lynne...
Biology of Blood and Marrow Transplantation. 20 (2014) 2 - p. S50 , 2014

Link: https://doi.org/10.1016/..